Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
BBWI Stock Summary
Top 10 Correlated ETFs
BBWI
In the News
BBWI Financial details
Company Rating
Sell
Market Cap
10.17B
Income
878M
Revenue
7.43B
Book val./share
-7.23
Cash/share
4.82
Dividend
0.8
Dividend %
1.78%
Employees
8.98K
Optionable
No
Shortable
Yes
Earnings
16 May 2024
P/E
13.96
Forward P/E
-
PEG
11.47
P/S
1.37
P/B
-4.82
P/C
8.96
P/FCF
13.05
Quick Ratio
0.43
Current Ratio
1.39
Debt / Equity
-2.81
LT Debt / Equity
-2.7
-
-
EPS (TTM)
3.87
EPS next Y
-
EPS next Q
-
EPS this Y
11.59%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
6.57%
Revenue Q/Q
86.43%
EPS Q/Q
394.23%
-
-
-
-
SMA20
-1.97%
SMA50
5.17%
SMA100
49.16%
Inst Own
68%
Inst Trans
0.73%
ROA
14%
ROE
-34%
ROC
0.32%
Gross Margin
43%
Oper. Margin
17%
Profit Margin
10%
Payout
25%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
27.3-50.34
52W High
-13.62%
52W Low
+59.96%
RSI
37.2
Rel Volume
0.73
Avg Volume
2.69M
Volume
1.96M
Perf Week
-7.61%
Perf Month
-4.24%
Perf Quarter
49.76%
Perf Half Y
37.64%
-
-
-
-
Beta
1.876
-
-
Volatility
1.07%, 1.75%
Prev Close
-1.14%
Price
43.19
Change
-3.2%
BBWI Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2024-02-03
Metric | History | 2020-02-01 | 2021-01-30 | 2022-01-29 | 2023-01-28 | 2024-02-03 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 19.58 | 23.14 | 29.3 | 32.59 | 32.58 | |
Net income per share | -1.33 | 3.04 | 4.96 | 3.45 | 3.85 | |
Operating cash flow per share | 4.48 | 7.33 | 5.55 | 4.93 | 4.18 | |
Free cash flow per share | 2.82 | 6.51 | 4.54 | 3.52 | 2.88 | |
Cash per share | 5.43 | 14.04 | 7.36 | 5.31 | 4.75 | |
Book value per share | -5.43 | -2.38 | -5.64 | -9.5 | -7.14 | |
Tangible book value per share | -9.18 | -6.12 | -8.59 | -12.92 | -10.61 | |
Share holders equity per share | -5.43 | -2.38 | -5.64 | -9.5 | -7.14 | |
Interest debt per share | 34.23 | 35.56 | 23.8 | 27.59 | 21.55 | |
Market cap | 5.17B | 9.16B | 14.7B | 10.36B | 9.91B | |
Enterprise value | 12.75B | 14.71B | 18.73B | 15.18B | 14.4B | |
P/E ratio | -14.12 | 10.85 | 11.03 | 12.95 | 11.28 | |
Price to sales ratio | 0.96 | 1.42 | 1.87 | 1.37 | 1.33 | |
POCF ratio | 4.18 | 4.49 | 9.85 | 9.05 | 10.38 | |
PFCF ratio | 6.64 | 5.06 | 12.03 | 12.69 | 15.1 | |
P/B Ratio | -3.45 | -13.84 | -9.68 | -4.7 | -6.09 | |
PTB ratio | -3.45 | -13.84 | -9.68 | -4.7 | -6.09 | |
EV to sales | 2.36 | 2.29 | 2.38 | 2.01 | 1.94 | |
Enterprise value over EBITDA | 8.14 | 7.09 | 8.62 | 9.41 | 9.28 | |
EV to operating cash flow | 10.31 | 7.22 | 12.56 | 13.27 | 15.09 | |
EV to free cash flow | 16.38 | 8.12 | 15.33 | 18.6 | 21.94 | |
Earnings yield | -0.07 | 0.09 | 0.09 | 0.08 | 0.09 | |
Free cash flow yield | 0.15 | 0.2 | 0.08 | 0.08 | 0.07 | |
Debt to equity | -6.06 | -14.28 | -3.96 | -2.75 | -2.81 | |
Debt to assets | 0.9 | 0.82 | 1 | 1.1 | 0.84 | |
Net debt to EBITDA | 4.84 | 2.68 | 1.86 | 2.99 | 2.89 | |
Current ratio | 1.37 | 1.97 | 2.33 | 1.64 | 1.64 | |
Interest coverage | 2.81 | 3.71 | 5.18 | 3.95 | 3.72 | |
Income quality | -3.38 | 2.42 | 1.12 | 1.43 | 1.09 | |
Dividend Yield | 0.06 | 0.01 | 0.01 | 0.02 | 0.02 | |
Payout ratio | -0.91 | 0.1 | 0.09 | 0.23 | 0.21 | |
Sales general and administrative to revenue | 0.25 | 0.23 | 0.23 | 0.25 | 0.26 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.1 | 0.09 | 0.13 | 0.14 | 0.15 | |
Capex to operating cash flow | -0.37 | -0.11 | -0.18 | -0.29 | -0.31 | |
Capex to revenue | -0.08 | -0.04 | -0.03 | -0.04 | -0.04 | |
Capex to depreciation | -0.78 | -0.44 | -0.74 | -1.48 | -1.11 | |
Stock based compensation to revenue | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham number | 12.73 | 12.75 | 25.08 | 27.16 | 24.87 | |
ROIC | 0.07 | 0.1 | 0.27 | 0.21 | 0.28 | |
Return on tangible assets | -0.04 | 0.08 | 0.25 | 0.17 | 0.19 | |
Graham Net | -33.51 | -26.95 | -18.7 | -25.62 | -24.04 | |
Working capital | 873M | 2.75B | 1.72B | 887M | 826M | |
Tangible asset value | -2.53B | -1.7B | -2.31B | -3B | -2.42B | |
Net current asset value | -8.38B | -6.65B | -4.53B | -5.43B | -4.97B | |
Invested capital | -6.06 | -14.28 | -3.96 | -2.75 | -2.81 | |
Average receivables | 336.5M | 287.5M | 254.5M | 233M | 225M | |
Average payables | 679M | 665M | 559M | 445M | 417.5M | |
Average inventory | 1.27B | 1.28B | 991M | 709M | 709.5M | |
Days sales outstanding | 20.66 | 15.26 | 11.11 | 10.91 | 11.01 | |
Days payables outstanding | 78.25 | 74.68 | 39.43 | 38.58 | 33.06 | |
Days of inventory on hand | 155.65 | 139.2 | 64.26 | 60.11 | 61.78 | |
Receivables turnover | 17.66 | 23.92 | 32.84 | 33.45 | 33.17 | |
Payables turnover | 4.66 | 4.89 | 9.26 | 9.46 | 11.04 | |
Inventory turnover | 2.34 | 2.62 | 5.68 | 6.07 | 5.91 | |
ROE | 0.24 | -1.27 | -0.88 | -0.36 | -0.54 | |
Capex per share | -1.66 | -0.82 | -1 | -1.41 | -1.31 |
Quarterly Fundamentals Overview
Last date of statement is 2024-02-03 for Q4
Metric | History | 2023-01-28 | 2023-04-29 | 2023-07-29 | 2023-10-28 | 2024-02-03 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 12.64 | 6.1 | 6.84 | 6.88 | 12.94 | |
Net income per share | 1.9 | 0.35 | 0.43 | 0.52 | 2.57 | |
Operating cash flow per share | 4.71 | 0.19 | 0.14 | -0.22 | 4.12 | |
Free cash flow per share | 4.38 | -0.21 | -0.23 | -0.53 | 3.9 | |
Cash per share | 5.39 | 4.57 | 3.46 | 1.81 | 4.82 | |
Book value per share | -9.65 | -9.48 | -9.45 | -9.36 | -7.23 | |
Tangible book value per share | -13.12 | -12.94 | -12.93 | -12.85 | -10.75 | |
Share holders equity per share | -9.65 | -9.48 | -9.45 | -9.36 | -7.23 | |
Interest debt per share | 26.88 | 26.49 | 26.21 | 25.52 | 20.69 | |
Market cap | 10.2B | 8.04B | 8.33B | 6.42B | 9.78B | |
Enterprise value | 15.02B | 12.97B | 13.43B | 11.72B | 14.27B | |
P/E ratio | 5.87 | 24.81 | 21.04 | 13.49 | 4.22 | |
Price to sales ratio | 3.53 | 5.76 | 5.34 | 4.11 | 3.36 | |
POCF ratio | 9.47 | 182.68 | 252.46 | -131.06 | 10.56 | |
PFCF ratio | 10.19 | -164.04 | -160.21 | -53.07 | 11.13 | |
P/B Ratio | -4.63 | -3.7 | -3.87 | -3.02 | -6.01 | |
PTB ratio | -4.63 | -3.7 | -3.87 | -3.02 | -6.01 | |
EV to sales | 5.2 | 9.29 | 8.62 | 7.5 | 4.9 | |
Enterprise value over EBITDA | 20.83 | 49.13 | 48.14 | 37.44 | 18.65 | |
EV to operating cash flow | 13.95 | 294.77 | 407.03 | -239.16 | 15.41 | |
EV to free cash flow | 15 | -264.69 | -258.31 | -96.85 | 16.25 | |
Earnings yield | 0.04 | 0.01 | 0.01 | 0.02 | 0.06 | |
Free cash flow yield | 0.1 | -0.01 | -0.01 | -0.02 | 0.09 | |
Debt to equity | -2.75 | -2.75 | -2.73 | -2.69 | -2.81 | |
Debt to assets | 1.1 | 1.11 | 1.13 | 1.09 | 0.84 | |
Net debt to EBITDA | 6.69 | 18.68 | 18.28 | 16.92 | 5.87 | |
Current ratio | 1.64 | 1.63 | 1.56 | 1.39 | 1.64 | |
Interest coverage | 7.58 | 2.03 | 2.19 | 2.63 | 8.08 | |
Income quality | 2.48 | 0.54 | 0.33 | -0.41 | 1.6 | |
Dividend Yield | 0 | 0.01 | 0.01 | 0.01 | 0 | |
Payout ratio | 0.11 | 0.57 | 0.46 | 0.38 | 0.08 | |
Sales general and administrative to revenue | 0.21 | 0.3 | 0.28 | 0.3 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.14 | 0.15 | 0.15 | 0.15 | 0.15 | |
Capex to operating cash flow | -0.07 | -2.11 | -2.58 | 1.47 | -0.05 | |
Capex to revenue | -0.03 | -0.07 | -0.05 | -0.05 | -0.02 | |
Capex to depreciation | -1.29 | -1.48 | -1.29 | -1.03 | -0.69 | |
Stock based compensation to revenue | 0 | 0.01 | 0.01 | 0.01 | 0 | |
Graham number | 20.31 | 8.68 | 9.61 | 10.51 | 20.46 | |
ROIC | 0.1 | 0.03 | 0.03 | 0.03 | 0.16 | |
Return on tangible assets | 0.09 | 0.02 | 0.02 | 0.03 | 0.12 | |
Graham Net | -26.02 | -26.17 | -26.47 | -27.33 | -24.36 | |
Working capital | 887M | 803M | 680M | 550M | 826M | |
Tangible asset value | -3B | -2.96B | -2.95B | -2.92B | -2.42B | |
Net current asset value | -5.43B | -5.45B | -5.46B | -5.41B | -4.97B | |
Invested capital | -2.75 | -2.75 | -2.73 | -2.69 | -2.81 | |
Average receivables | 234M | 185.5M | 149M | 175M | 210.5M | |
Average payables | 543.5M | 440.5M | 467M | 567.5M | 503.5M | |
Average inventory | 989M | 740M | 794.5M | 1.01B | 957.5M | |
Days sales outstanding | 7.04 | 9.35 | 8.83 | 11.35 | 6.92 | |
Days payables outstanding | 24.98 | 47.93 | 48.79 | 64.13 | 21.7 | |
Days of inventory on hand | 38.93 | 86.74 | 78.57 | 123.24 | 40.55 | |
Receivables turnover | 12.78 | 9.63 | 10.19 | 7.93 | 13 | |
Payables turnover | 3.6 | 1.88 | 1.84 | 1.4 | 4.15 | |
Inventory turnover | 2.31 | 1.04 | 1.15 | 0.73 | 2.22 | |
ROE | -0.2 | -0.04 | -0.05 | -0.06 | -0.36 | |
Capex per share | -0.33 | -0.41 | -0.37 | -0.32 | -0.21 |
BBWI Frequently Asked Questions
What is Bath & Body Works, Inc. stock symbol ?
Bath & Body Works, Inc. is a US stock , located in Columbus of Oh and trading under the symbol BBWI
What is Bath & Body Works, Inc. stock quote today ?
Bath & Body Works, Inc. stock price is $43.19 today.
Is Bath & Body Works, Inc. stock public?
Yes, Bath & Body Works, Inc. is a publicly traded company.